Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Casting a wider net: Immunosurveillance by nonclassical MHC molecules

Casting a wider net: Immunosurveillance by nonclassical MHC molecules

Thumbnail Image
Download
Name

journal.ppat.1007567.pdf

Description
Published version
Size

1.17 MB

Format

Adobe PDF

Checksum (MD5)

de6205bf8c5aae32cfa34cb3bffd1718

sword-2020-02-11T13:17:12.original.xml (130 B)
Original SWORD entry document
Author(s)
Birnbaum, Michael E.
Date Issued
February 21, 2019
Journal
PloS one
Publisher
Public Library of Science (PLoS)
Citation
D’Souza, M. Patricia et al. "Casting a wider net: Immunosurveillance by nonclassical MHC molecules." PloS one 15 (2019)
Version
Final published version
Abstract
Most studies of T lymphocytes focus on recognition of classical major histocompatibility complex (MHC) class I or II molecules presenting oligopeptides, yet there are numerous variations and exceptions of biological significance based on recognition of a wide variety of nonclassical MHC molecules. These include αβ and γδ T cells that recognize different class Ib molecules (CD1, MR-1, HLA-E, G, F, et al.) that are nearly monomorphic within a given species. Collectively, these T cells can be considered “unconventional,” in part because they recognize lipids, metabolites, and modified peptides. Unlike classical MHC-specific cells, unconventional T cells generally exhibit limited T-cell antigen receptor (TCR) repertoires and often produce innate immune cell-like rapid effector responses. Exploiting this system in new generation vaccines for human immunodeficiency virus (HIV), tuberculosis (TB), other infectious agents, and cancer was the focus of a recent workshop, “Immune Surveillance by Non-classical MHC Molecules: Improving Diversity for Antigens,” sponsored by the National Institute of Allergy and Infectious Diseases. Here, we summarize salient points presented regarding the basic immunobiology of unconventional T cells, recent advances in methodologies to measure unconventional T-cell activity in diseases, and approaches to harness their considerable clinical potential.
Subjects
Immunology
Genetics
Molecular Biology
Microbiology
Parasitology
Virology
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution 4.0 International license
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/124454
DOI of Published Version
https://doi.org/10.1371/journal.ppat.1007567
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.